Your browser doesn't support javascript.
loading
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri, Chirag D; Glassman, Adam R; Ferris, Frederick L; Liu, Danni; Maguire, Maureen G; Allen, John B; Baker, Carl W; Browning, David; Cunningham, Matthew A; Friedman, Scott M; Jampol, Lee M; Marcus, Dennis M; Martin, Daniel F; Preston, Carin M; Stockdale, Cynthia R; Sun, Jennifer K.
Afiliación
  • Jhaveri CD; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Glassman AR; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Ferris FL; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Liu D; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Maguire MG; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Allen JB; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Baker CW; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Browning D; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Cunningham MA; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Friedman SM; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Jampol LM; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Marcus DM; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Martin DF; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Preston CM; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Stockdale CR; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
  • Sun JK; From the Retina Consultants of Austin and the Austin Research Center for Retina - both in Austin, TX (C.D.J.); the Jaeb Center for Health Research, Tampa (A.R.G., D.L., M.G.M., C.M.P., C.R.S.), the Florida Retina Institute, Orlando (M.A.C.), and Florida Retina Consultants, Lakeland (S.M.F.) - all in
N Engl J Med ; 387(8): 692-703, 2022 08 25.
Article en En | MEDLINE | ID: mdl-35833805
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Edema Macular / Inhibidores de la Angiogénesis / Receptores de Factores de Crecimiento Endotelial Vascular / Retinopatía Diabética / Bevacizumab Tipo de estudio: Clinical_trials / Etiology_studies / Guideline Límite: Adult / Humans Idioma: En Revista: N Engl J Med Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Edema Macular / Inhibidores de la Angiogénesis / Receptores de Factores de Crecimiento Endotelial Vascular / Retinopatía Diabética / Bevacizumab Tipo de estudio: Clinical_trials / Etiology_studies / Guideline Límite: Adult / Humans Idioma: En Revista: N Engl J Med Año: 2022 Tipo del documento: Article